New hope for advanced breast cancer: experimental drug ARV-471 shows promise in early trial
NCT ID NCT04072952
First seen Nov 01, 2025 · Last updated May 12, 2026 · Updated 16 times
Summary
This study tested an experimental drug called ARV-471, alone or with another drug (palbociclib), in 217 people with a common type of advanced breast cancer (ER+/HER2-) that had stopped responding to standard treatments. The main goals were to check safety and see if the drug shrinks tumors or keeps them stable for at least 24 weeks. Participants had already received hormone therapy and chemotherapy.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Clinical Trial Site
Palo Alto, California, 94304, United States
-
Clinical Trial Site
San Francisco, California, 94158, United States
-
Clinical Trial Site
Santa Monica, California, 90404, United States
-
Clinical Trial Site
Norwalk, Connecticut, 06856, United States
-
Clinical Trial Site
Fort Myers, Florida, 33901, United States
-
Clinical Trial Site
Tampa, Florida, 33612, United States
-
Clinical Trial Site
Chicago, Illinois, 60637, United States
-
Clinical Trial Site
Boston, Massachusetts, 02114, United States
-
Clinical Trial Site
Boston, Massachusetts, 02215, United States
-
Clinical Trial Site
Ann Arbor, Michigan, 48109, United States
-
Clinical Trial Site
St Louis, Missouri, 63110, United States
-
Clinical Trial Site
East Brunswick, New Jersey, 08816, United States
-
Clinical Trial Site
The Bronx, New York, 10461, United States
-
Clinical Trial Site
Charlotte, North Carolina, 28204, United States
-
Clinical Trial Site
Nashville, Tennessee, 37203, United States
-
Clinical Trial Site
Seattle, Washington, 98109, United States
Conditions
Explore the condition pages connected to this study.